Aradigm Corporation Logo

Email this page: News Release

Aradigm Presents Phase 2 Data on Inhaled Liposomal Ciprofloxacin in Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis at 2009 International Conference of the American Thoracic Society


Separate multiple addresses with commas. Maximum 200 characters.

These email addresses will be used to email the page on your behalf and will not be used by Aradigm Corporation for any marketing purposes.


This helps Aradigm Corporation prevent automated submissions.